Both in Pharmaceuticals
MoonLake Immunotherapeutics vs Corvus Pharmaceuticals
Over the past year MLTX returned +38.0% and CRVS returned +43.8%; their daily moves had a correlation of 0.13.
MLTX +38.0% CRVS +43.8%Growth of $1, one year, split-adjusted
| Metric | MLTX | CRVS |
|---|---|---|
| Price | $12.64 | $10.35 |
| Market cap | $1.08B | $870.8M |
| Today | +18.69% | +3.00% |
| 1 month | −2.0% | −17.5% |
| 6 months | −25.3% | −35.4% |
| Year to date | −4.1% | +34.4% |
| 1 year | +38.0% | +43.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $437.5M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 51.2% |
| Short % of float | 14.7% | 25.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).